Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced the appointment of Matthew E. Ros as...
Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
